ACC Statement Aims to Build Civil, Respectful and Bully-Free Work Environments

Health policy statement outlines organizational and individual strategies to address bias, discrimination, bullying and harassment

ACC: Successfully addressing bias, discrimination, bullying and harassment in the workplace requires institutional dedication; visible, supportive leadership; and adequate financial resources for implementing effective policies and procedures, according to an American College of Cardiology (ACC) health policy statement published in the Journal of the American College of Cardiology.

“This document is not merely a position statement, but it is a call-to-action that articulates solutions and provides resources and tools for individuals, organizations and professional societies who wish to address the widespread problem of bias, discrimination, bullying and harassment in cardiology,” said Pamela S. Douglas, MD, MACC, co-chair of the health policy statement. “The ramifications of not tackling these issues cannot be ignored, as uncivil behavior impacts employee retention, well-being, and has potentially high costs for the institution or practice.”

Uncivil and toxic behavior, including bias, discrimination, bullying and harassment, has been well-documented in medicine and cardiology. A recent survey found over one-third of resident doctors and faculty reported experiencing bias, discrimination, bullying and harassment at their main place of work and the behaviors were more commonly reported as directed toward women and racial/ethnic minorities. Uncivil behaviors are a spectrum, including microaggressions and implicit bias on one end, and harassment and violence on the other. The behaviors can be intentional or unintentional, refer to many personal identities (including but not limited to age, religion, sexual orientation, gender identity, physical ability, professional role, appearance, clothing and country of origin) and are the result of individual, organizational and societal issues. Recent years have placed emphasis on diversity, equity and inclusion, but according to the statement authors, “belonging” needs to be recognized to address critical cultural issues.

“In order to implement meaningful, successful approaches to addressing bias, discrimination, bullying and harassment, each initiative must be tailored to individual and institutional needs,” said Michael Mack, MD, MACC, co-chair of the health policy statement. “Medical and professional societies have a unique role in setting standards of excellence and acting as influencers to drive change in building safe and healthy work cultures.”

Among the recommendations set by the authors to help eliminate bias, discrimination, bullying and harassment:

  • Establishing confidential and fair mechanisms for reporting and investigating individuals and/or departments suspected or accused of bias, discrimination, bullying and harassment.
  • Creating institutional resources to ensure that hiring decisions and performance evaluations are objective.
  • Adopting metrics supported by data collection to track progress and inform future plans.
  • Embracing independent evaluation of culture and the effectiveness of efforts to reduce uncivil behavior.
  • Recognizing champions and leaders who promote and model excellence in these areas.

The 2022 ACC Health Policy Statement on Building Respect, Civility, and Inclusion in the Cardiovascular Workforce will be discussed in a session at the American College of Cardiology’s 71st Annual Scientific Session on April 2 at 4:15 p.m. ET. Learn more about the session here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version